182 related articles for article (PubMed ID: 25621296)
21. The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer.
Weng M; Luo ZL; Wu XL; Zeng WZ
Oncotarget; 2017 Mar; 8(12):20288-20296. PubMed ID: 28423617
[TBL] [Abstract][Full Text] [Related]
22. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
[TBL] [Abstract][Full Text] [Related]
23. NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Huang ZJ; Zhu JJ; Yang XY; Biskup E
Oncol Lett; 2017 Sep; 14(3):2649-2656. PubMed ID: 28928809
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
25. Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells.
Qin Y; Xu SQ; Pan DB; Ye GX; Wu CJ; Wang S; Wang CJ; Jiang JY; Fu J
Tumour Biol; 2016 May; 37(5):6787-99. PubMed ID: 26662306
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
27. ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.
Kimura Y; Kasamatsu A; Nakashima D; Yamatoji M; Minakawa Y; Koike K; Fushimi K; Higo M; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
J Cancer; 2016; 7(6):702-10. PubMed ID: 27076852
[TBL] [Abstract][Full Text] [Related]
28. Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells.
Li H; Zhang Z; Wang B; Zhang J; Zhao Y; Jin Y
Mol Cell Biol; 2007 Aug; 27(15):5296-305. PubMed ID: 17526739
[TBL] [Abstract][Full Text] [Related]
29. WWP2 ubiquitin ligase and its isoforms: new biological insight and promising disease targets.
Chantry A
Cell Cycle; 2011 Aug; 10(15):2437-9. PubMed ID: 21750408
[TBL] [Abstract][Full Text] [Related]
30. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
[TBL] [Abstract][Full Text] [Related]
31. Expression and purification of human WWP2 HECT domain in Escherichia coli.
Jiang J; Zheng J; She Y; Jia Z
Protein Expr Purif; 2015 Jun; 110():95-101. PubMed ID: 25554193
[TBL] [Abstract][Full Text] [Related]
32. Expression of WW domain-containing protein 2 is correlated with pathological grade and recurrence of glioma.
Liang J; Qi WF; Xie S; Wang WF; Zhang XL; Zhou XP; ; Hu JX; Yu RT
J Cancer Res Ther; 2017; 13(6):1032-1037. PubMed ID: 29237971
[TBL] [Abstract][Full Text] [Related]
33. Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner.
Liao B; Jin Y
Cell Res; 2010 Mar; 20(3):332-44. PubMed ID: 19997087
[TBL] [Abstract][Full Text] [Related]
34. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
35. USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma.
Qu Z; Zhang R; Su M; Liu W
Cancer Manag Res; 2019; 11():9175-9183. PubMed ID: 31802942
[TBL] [Abstract][Full Text] [Related]
36. Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.
Miyamoto I; Kasamatsu A; Yamatoji M; Nakashima D; Saito K; Higo M; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Rep; 2015 Sep; 3():26-31. PubMed ID: 29124166
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
Lau MT; Klausen C; Leung PC
Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
[TBL] [Abstract][Full Text] [Related]
38. PTEN and NEDD4 in Human Breast Carcinoma.
Chen Y; van de Vijver MJ; Hibshoosh H; Parsons R; Saal LH
Pathol Oncol Res; 2016 Jan; 22(1):41-7. PubMed ID: 26276352
[TBL] [Abstract][Full Text] [Related]
39. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
